Depomed, Inc.

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

Depomed, Inc. is a pharmaceutical manufacturing company focused on developing and commercializing medicines for neuropathic pain, migraine, and areas of unmet medical need through its Neurology and Pain Business and an emerging Specialty Business. The firm aims to improve patient outcomes by offering therapeutic options that address underserved populations, and its three-pillar growth strategy centers on maintaining a profitable Neuyn franchise through a commercialization agreement, expanding its Neurology and Pain operations, and building the Specialty Business via recent strategic transactions. Based in Newark, California, the company positions itself in the pharmaceutical industry as a specialty player pursuing licenses and development opportunities that broaden treatment options for patients, providers, payors, and families. Depomed operates as a publicly traded company on NASDAQ under the ticker DEPO and describes itself as relocating its headquarters as part of its transformation; its workforce is described in general terms as diverse. A notable development noted in recent context is the acquisition-related transition of certain marketing and distribution rights from Janssen Pharmaceuticals in 2017.

Sign up for free to view info

Email Format Employee directory